AbbVie Contract Manufacturing AbbVie Contract Manufacturing

X

CAS 477600-73-0 manufacturers and suppliers on PharmaCompass

PharmaCompass
CAS 477600-73-0
Also known as: 477600-73-0, N-[(3r,4r)-1-benzyl-4-methylpiperidin-3-yl]-n-methyl-7h-pyrrolo[2,3-d]pyrimidin-4-amine, Tofacitinib benzyl analog, 7h-pyrrolo[2,3-d]pyrimidin-4-amine, n-methyl-n-[(3r,4r)-4-methyl-1-(phenylmethyl)-3-piperidinyl]-, Chembl2152298, K35a6384qd
Molecular Formula
C20H25N5
Molecular Weight
335.4  g/mol
InChI Key
UMWNXPTXDOVDFE-QAPCUYQASA-N
FDA UNII
K35A6384QD

1 2D Structure

CAS 477600-73-0

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
N-[(3R,4R)-1-benzyl-4-methylpiperidin-3-yl]-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine
2.1.2 InChI
InChI=1S/C20H25N5/c1-15-9-11-25(12-16-6-4-3-5-7-16)13-18(15)24(2)20-17-8-10-21-19(17)22-14-23-20/h3-8,10,14-15,18H,9,11-13H2,1-2H3,(H,21,22,23)/t15-,18+/m1/s1
2.1.3 InChI Key
UMWNXPTXDOVDFE-QAPCUYQASA-N
2.1.4 Canonical SMILES
CC1CCN(CC1N(C)C2=NC=NC3=C2C=CN3)CC4=CC=CC=C4
2.1.5 Isomeric SMILES
C[C@@H]1CCN(C[C@@H]1N(C)C2=NC=NC3=C2C=CN3)CC4=CC=CC=C4
2.2 Other Identifiers
2.2.1 UNII
K35A6384QD
2.3 Synonyms
2.3.1 Depositor-Supplied Synonyms

1. 477600-73-0

2. N-[(3r,4r)-1-benzyl-4-methylpiperidin-3-yl]-n-methyl-7h-pyrrolo[2,3-d]pyrimidin-4-amine

3. Tofacitinib Benzyl Analog

4. 7h-pyrrolo[2,3-d]pyrimidin-4-amine, N-methyl-n-[(3r,4r)-4-methyl-1-(phenylmethyl)-3-piperidinyl]-

5. Chembl2152298

6. K35a6384qd

7. Des-(n-oxopropanenitrile)-n-methylbenzyl Cp-690550

8. Tofacitinib Des-(n-oxopropanenitrile)-n-methylbenzyl

9. N-((3r,4r)-1-benzyl-4-methylpiperidin-3-yl)-n-methyl-7h-pyrrolo(2,3-d)pyrimidin-4-amine

10. N-[(3r,4r)-1-benzyl-4-methyl-3-piperidyl]-n-methyl-7h-pyrrolo[2,3-d]pyrimidin-4-amine

11. 7h-pyrrolo(2,3-d)pyrimidin-4-amine, N-methyl-n-((3r,4r)-4-methyl-1-(phenylmethyl)-3-piperidinyl)-

12. 1h-pyrrolo[2,3-d]pyrimidin-4-amine,n-methyl-n-[(3r,4r)-4-methyl-1-(phenylmethyl)-3-piperidinyl]-

13. Unii-k35a6384qd

14. Schembl1120769

15. Dtxsid30678791

16. Amy22112

17. Cua60073

18. Bdbm50391994

19. Mfcd16877475

20. Zinc38847049

21. (3r,4r)-(1-benzyl-4-methyl-piperidin-3-yl)-methyl-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-amine

22. Ac-29725

23. Ds-17205

24. C75274

25. (3r,4r)-(1-benzyl-4-methyl-piperidin-3yl)-methyl-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)amine

26. [(3r,4r)-1-benzyl-4-methyl-piperidin-3-yl]-methyl-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-amine

27. N-methyl-n-((3r,4r)-4-methyl-1-(phenylmethyl)-3-piperidinyl)-7h-pyrrolo[2,3-d]pyrimidin-4-amine

2.4 Create Date
2011-02-14
3 Chemical and Physical Properties
Molecular Weight 335.4 g/mol
Molecular Formula C20H25N5
XLogP33.6
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count4
Rotatable Bond Count4
Exact Mass335.21099582 g/mol
Monoisotopic Mass335.21099582 g/mol
Topological Polar Surface Area48 Ų
Heavy Atom Count25
Formal Charge0
Complexity424
Isotope Atom Count0
Defined Atom Stereocenter Count2
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
Flag China
Digital Content Digital Content
URL Supplier Web Content
1062580-52-2
Tofacitinib Citrate
Hiray Pharma Solutions is an international end-to-end CDMO, facilitating the development and manufacturin...
Hiray Pharma Solutions is an international end-to-end CDMO, facilitating the development and manufacturing of important drug products and key intermediates around the world. We provide the best chemical techniques, control, and manufacturing services to pharmaceutical and innovative enterprises, and a swift path for fine medicine to benefit patients. As an end-to-end CDMO, Hiray can provide on-time, high-quality service for Process R&D, Analytical R&D, Manufacturing, and Quality Control. Hiray operates in strict compliance with, or exceeds, the latest standards for safety, health, and the environment.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag China
Digital Content Digital Content
URL Supplier Web Content
479633-63-1
Tofacitinib Citrate
Hiray Pharma Solutions is an international end-to-end CDMO, facilitating the development and manufacturin...
Hiray Pharma Solutions is an international end-to-end CDMO, facilitating the development and manufacturing of important drug products and key intermediates around the world. We provide the best chemical techniques, control, and manufacturing services to pharmaceutical and innovative enterprises, and a swift path for fine medicine to benefit patients. As an end-to-end CDMO, Hiray can provide on-time, high-quality service for Process R&D, Analytical R&D, Manufacturing, and Quality Control. Hiray operates in strict compliance with, or exceeds, the latest standards for safety, health, and the environment.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY